Knee Arthrosis Clinical Trial
Official title:
Gebruik Van Stromale Vasculaire Fractie Uit Vetweefsel na Invriezing Voor Knie Arthrose
A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis. Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in our laboratory. The SVF will then be injected up to 2 times into the fat pad of the patient's knee.
Status | Recruiting |
Enrollment | 10 |
Est. completion date | December 31, 2026 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Legal capacity - Osteochondral lesions - Inflammatory complaints - (Peri)tendinitis or tendinopathies and ligamentous injuries - Impingement complaints - Arthrofibrosis - Anterior knee pain |
Country | Name | City | State |
---|---|---|---|
Belgium | UZ GENT | Gent | Oost-Vlaanderen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Ghent |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the safety of SVF injections after cryo preservation | The patient will complete the KOOS questionnaire (Knee Injury and Osteoarthritis Outcome Score) on several timepoints. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01206634 -
Regenerative Injection Therapy and Osteoarthritis
|
Phase 4 | |
Not yet recruiting |
NCT04001699 -
Interprofessional Preoperative Geriatric Assessment for Older Arthroplasty Patients With Multimorbidity
|
N/A |